Senile-Onset Subacute Sclerosing Panencephalitis, Presenting With Peculiar Findings

Subacute sclerosing panencephalitis (SSPE) is a well-known childhood disease; however, the adult onset of SSPE cases are also widely recognized where the oldest case reported is 52 years old. We report a 61-year-old woman patient presenting with atypical clinical and EEG features, diagnosed with SSP...

Full description

Saved in:
Bibliographic Details
Published in:Clinical EEG and neuroscience 2019-07, Vol.50 (4), p.283-286
Main Authors: Elmali, Ayse Deniz, Simsekoglu, Ruken, Sahin, Erdi, Duman Ilki, Canan, Uygun, Ozge, Coban, Oguzhan, Gurses, Candan
Format: Article
Language:English
Subjects:
Antibodies, Viral - blood
Antibodies, Viral - cerebrospinal fluid
Brain - physiopathology
Children
Differential diagnosis
Disease transmission
Displaced persons
Disruption
EEG
Electroencephalography
Female
Human settlements
Humans
Immunization
Measles
Measles - complications
Middle Aged
Mumps
Outbreaks
Panencephalitis
Patients
Refugees
Subacute sclerosing panencephalitis
Subacute Sclerosing Panencephalitis - diagnosis
Subacute Sclerosing Panencephalitis - physiopathology
Subacute Sclerosing Panencephalitis - virology
Vaccination
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Subacute sclerosing panencephalitis (SSPE) is a well-known childhood disease; however, the adult onset of SSPE cases are also widely recognized where the oldest case reported is 52 years old. We report a 61-year-old woman patient presenting with atypical clinical and EEG features, diagnosed with SSPE. Measles and SSPE have decreased dramatically owing to worldwide immunization programs; however, there are still reasons to consider SSPE in differential diagnosis even in patients presenting with atypical clinical findings and older ages. First, there is a generation who missed the immunization era, constituting a latent disease pool. Second, antivaccination movements have led to a decline in MMR (measles, mumps, rubella) vaccination worldwide, leading to measles outbreaks and potential future SSPE cases. Third, most of the vaccination programs start measles immunization at the age of 12 months, leading to a shift in the incidence below the age of 1 year, when the risk of developing SSPE in adult life is higher. Finally, disruption in vaccination programs, in which fast disease transmission due to close contact living, unhygienic conditions of refugee camps, and limited access to health care in displaced populations have also led to measles outbreaks. In conclusion, we believe that neurologists for adults should consider SSPE in differential diagnosis, even in older patients with atypical presentations.
ISSN:1550-0594
2169-5202
DOI:10.1177/1550059418793758